Improved mammalian expression vectors and uses thereof

Details for Australian Patent Application No. 2009206089 (hide)

Owner Abbott Laboratories

Inventors Hsieh, Chung-Ming

Agent Spruson & Ferguson

Pub. Number AU-A-2009206089

PCT Pub. Number WO2009/091912

Priority 61/021,282 15.01.08 US; 61/104,546 10.10.08 US

Filing date 15 January 2009

Wipo publication date 23 July 2009

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/091912 Priority application(s): WO2009/091912

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009206092-Combination therapy comprising actinidia and steroids and uses thereof

2009206082-Methods of treating bone-loss disorders using a GM-CSF antagonist